Conducting Research with OBRI
The OBRI is a rheumatology data platform (initially established in 2005) that currently follows more than 3500 rheumatoid arthritis patients. The provincial cohort combines real world clinical data collected by rheumatologists as well as patient self-reported outcomes via telephone interviews. The clinical data collected can be linked to administrative data at the Institute for Clinical Evaluative Sciences (ICES).
The goal of the OBRI is to monitor comparative drug effectiveness, safety and quality of care in the real world. Our research priorities include the examination of:
1) Drug Impact and Outcomes (effectiveness, safety, adherence persistence/survival);
2) Clinical Management and Practice Patterns vs. Guidelines (clinical measures, quality indicators, practice guidelines), and
3) Population Health (epidemiology, models of care, economics).
Our data management and research team work closely with a clinical advisory committee to address important and relevant clinical questions. Findings are presented at international meetings and used to improve clinical practice.
In an effort to support research and innovation, we would like to invite medical students/residents with an interest in musculoskeletal conditions or inflammatory arthritis to work with the OBRI team. The OBRI team commits to support 1 trainee research project each year.
Please see the process outlined below.
- Contact OBRI for a list of ongoing and completed research questions (Angela Cesta: email@example.com)
- Collaborate with an OBRI investigator and submit the completed OBRI Research Question Proposal Form (Part I) by August 31st, 2017.
- Research questions submitted are reviewed and prioritized by the OBRI Clinical Advisory Committee
- Selected trainee will be invited to collaborate with the OBRI team.
Applications must be received by August 31st.